Pancreatic Cancer Research

ResearcherUniversity of FoggiaActive in the last 2 years

Carolina Torres

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7908-6884; OpenAlex author ID A5047406533. Sources: OpenAlex.

Their work

Papers
19 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2014: 2 papers · 2015: 2 papers · 2016: 3 papers · 2017: none · 2018: 5 papers · 2019: 2 papers · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: 2 papers

Papers 19

  1. Potential clinical applications of extracellular vesicles in pancreatic cancer: exploring untapped opportunities from biomarkers to novel therapeutic approache… Co-author DOI 10.20517/evcna.2023.68↗
  2. Cell Membrane Fatty Acids and PIPs Modulate the Etiology of Pancreatic Cancer by Regulating AKT. Co-author DOI 10.3390/nu17010150↗
  3. Role of stromal activin A in human pancreatic cancer and metastasis in mice. First author DOI 10.1038/s41598-021-87213-y↗
  4. Liquid biopsy approach to pancreatic cancer. First author DOI 10.4251/wjgo.v13.i10.1263↗
  5. Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer. Co-author DOI 10.1016/j.ajps.2020.02.003↗
  6. Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer. Co-author DOI 10.1038/s41598-019-47566-x↗
  7. TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-18-0850↗
  8. KRAS G12D and TP53R167H Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa Pigs. Co-author DOI 10.1038/s41598-018-30916-6↗
  9. Pancreatic cancer subtypes: a roadmap for precision medicine. Co-author DOI 10.1080/07853890.2018.1453168↗
  10. Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers. Co-author DOI 10.1371/journal.pone.0194844↗
  11. Proteomic biomarkers in body fluids associated with pancreatic cancer. First author DOI 10.18632/oncotarget.24654↗
  12. The Complexity of Omega-3 Fatty Acid Modulation of Signaling Pathways Related to Pancreatic Cancer. Co-author DOI 10.2174/0929867324666170616111225↗
  13. Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients. Co-author DOI 10.1016/j.taap.2016.10.003↗
  14. Current Status of Immunotherapy Treatments for Pancreatic Cancer. Co-author DOI 10.1097/mcg.0000000000000623↗
  15. Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells. Co-author DOI 10.1097/mpa.0000000000000452↗
  16. The potential role of the glycoprotein osteoactivin/glycoprotein nonmetastatic melanoma protein B in pancreatic cancer. Co-author DOI 10.1097/mpa.0000000000000250↗
  17. Prognosis Relevance of Serum Cytokines in Pancreatic Cancer. Co-author DOI 10.1155/2015/518284↗
  18. Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. Co-author DOI 10.1007/s10620-014-3291-3↗
  19. Serum cytokine profile in patients with pancreatic cancer. Co-author DOI 10.1097/mpa.0000000000000155↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Paul J. Grippo · 8 shared papers, 2018–2024 · strength 0.90
  2. Sonia Perales · 7 shared papers, 2014–2024 · strength 0.64
  3. Joaquina Martínez-Galán · 5 shared papers, 2015–2024 · strength 0.59
  4. Jose Carlos Prados · 8 shared papers, 2014–2021 · strength 0.55
  5. Octavio Caba · 7 shared papers, 2014–2021 · strength 0.51
  6. Cristina Jiménez‐Luna · 6 shared papers, 2014–2021 · strength 0.47
  7. Jose Manuel Sanchez-Manas · 2 shared papers, 2021–2024 · strength 0.41
  8. Georgina E. Mancinelli · 3 shared papers, 2019–2024 · strength 0.37
  9. Daniel R. Principe · 3 shared papers, 2018–2019 · strength 0.27
  10. Pedro J. Real · 1 shared paper, 2024 · strength 0.26
  11. Antonio Irigoyen · 5 shared papers, 2014–2018 · strength 0.25
  12. Ana Linares · 5 shared papers, 2014–2016 · strength 0.24
  13. Raúl Ortíz · 3 shared papers, 2014–2018 · strength 0.19
  14. Consolación Melguizo · 3 shared papers, 2014–2018 · strength 0.19
  15. David W. Dawson · 2 shared papers, 2018–2021 · strength 0.19
  16. Megha Singhal · 1 shared paper, 2024 · strength 0.16
  17. Giulia Orsi · 1 shared paper, 2024 · strength 0.16
  18. Faraz Bishehsari · 1 shared paper, 2024 · strength 0.16
  19. Ajay Nmn Rana · 2 shared papers, 2018–2019 · strength 0.16
  20. Hidayatullah G. Munshi · 2 shared papers, 2018–2019 · strength 0.16
  21. Manuel Benavides · 2 shared papers, 2016–2018 · strength 0.13
  22. Javier Gallego-Plazas · 2 shared papers, 2016–2018 · strength 0.13
  23. Carmen Guillén‐Ponce · 2 shared papers, 2016–2018 · strength 0.13
  24. Enrique Aranda · 2 shared papers, 2016–2018 · strength 0.13
  25. Rosa F. Hwang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.